Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid Stefan R. VinkJan H. M. SchellensMarcel Verheij OriginalPaper Pages: 279 - 286
Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP Beata KosmiderIzabela WojcikPawel Liberski OriginalPaper Pages: 287 - 297
A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines Kongming WuMark D’AmicoSridhar Mani OriginalPaper Pages: 299 - 309
A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer Kim N. ChiStephen K. ChiaKaren A. Gelmon OriginalPaper Pages: 311 - 315
Human metabolism of [14C]indisulam following i.v. infusion in cancer patients Jan-Hendrik BeumerMichel J. X. HillebrandJos H. Beijnen OriginalPaper Pages: 317 - 330
Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer Takahiko SugiuraYutaka AriyoshiMasahiro Fukuoka OriginalPaper Pages: 331 - 337
DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors Moritz N. WenteJörg KleeffHelmut Friess OriginalPaper Pages: 339 - 347
Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study Peter SchmidBernd FlathKurt Possinger OriginalPaper Pages: 349 - 356
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme Susan M. ChangPatrick WenNorth American Brain Tumor Consortium and the National Cancer Institute OriginalPaper Pages: 357 - 361
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR) R.-D. HofheinzC. PortaA. Hochhaus OriginalPaper Pages: 363 - 368
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study Nicolas TsavarisChristos KosmasEfstathios Papalambros OriginalPaper Pages: 369 - 375
Phase I Study of Tomudex and Doxorubicin in Patients with Locally Advanced, Inoperable or Metastatic Cancer (IND.98) Editorial Board Erratum Pages: 377 - 377
Pomegranate (Punica granatum) Pure Chemicals Show Possible Synergistic Inhibition of Human PC-3 Prostate Cancer Cell Invasion Across Matrigeltm Editorial Board Erratum Pages: 379 - 379